Semenyuta, I.V.* ; Trush, M.M.* ; Kovalishyn, V.V.* ; Rogalsky, S.P.* ; Hodyna, D.M.* ; Karpov, P. ; Xia, Z. ; Tetko, I.V. ; Metelytsia, L.O.*
Structure-activity relationship modeling and experimental validation of the imidazolium and pyridinium based ionic liquids as potential antibacterials of mdr Acinetobacter baumannii and Staphylococcus aureus.
Int. J. Mol. Sci. 22:563 (2021)
Online Chemical Modeling Environment (OCHEM) was used for QSAR analysis of a set of ionic liquids (ILs) tested against multi-drug resistant (MDR) clinical isolate Acinetobacter baumannii and Staphylococcus aureus strains. The predictive accuracy of regression models has coefficient of determination q2 = 0.66 − 0.79 with cross-validation and independent test sets. The models were used to screen a virtual chemical library of ILs, which was designed with targeted activity against MDR Acinetobacter baumannii and Staphylococcus aureus strains. Seven most promising ILs were selected, synthesized, and tested. Three ILs showed high activity against both these MDR clinical isolates.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Acinetobacter Baumannii ; Enoyl-acp Reductase ; Fabi ; Guanidinium ; Imidazolium ; Ionic Liquids (ils) ; Ochem ; Pyridinium ; Qsar ; Staphylococcus Aureus ; Structure-activity Modeling
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
1661-6596
e-ISSN
1422-0067
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 22,
Issue: 2,
Pages: ,
Article Number: 563
Supplement: ,
Series
Publisher
MDPI
Publishing Place
Basel
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503000-001
Grants
Bundesministerium für Bildung, Wissenschaft und Forschung
China Scholarship Council (CSC)
German Federal Ministry for education and research (BMBF)
Copyright
Erfassungsdatum
2021-03-25